{"id": "1371796049845751812", "creation": 1615896639.0, "user_id": "5383942", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 8, "reply_count": 1, "like_count": 30, "quote_count": 2}}, "text": "#News for #investors and #media: We\u2019re pleased to announce the start of a Phase 3 trial of @medicagoinc\u2019s adjuvanted #COVID19 #vaccine candidate, combining their plant-derived Virus-Like Particle technology with our pandemic adjuvant. https://t.co/VKfbzwT5oE https://t.co/qIszQCuFmf", "first_save": 1634559108.199414, "hashtags": ["#NEWS", "#INVESTORS", "#MEDIA", "#COVID19", "#VACCINE"]}